Tags: canada + drugs.with.MS

Sort by: Date / Title / URL

1. The Canadian Press: Drug body's advice against provinces paying for MS drugs seen as unfair
   An expert panel's advice that provinces and territories not cover the cost of two Multiple Sclerosis drugs creates a system of two-tiered care, MS advocates say.
   16-10-2007 to canada, drugs, government, sativex, tysabri by admin
2. CEDAC Recommendation on Tysabri
   Decision of the CEDAC (Canada) on the use of Tysabri (natalizumab)
   29-07-2007 to canada, drugs, government, natalizumab, tysabri by admin
3. BioMS Medical Announces Lead Investigator In United States Phase III Multiple Sclerosis Trial
   BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), is pleased to announce Dr. Clyde E. Markowitz as the lead investigator in the United States for the Company’s pivotal phase III clinical trial of its lead dru
   28-04-2007 to canada, drug company, drugs, mbp8298, multiple sclerosis, spms by admin
4. Secret bonuses could have helped 7 patients: MS society
   The money quietly paid to 46 Newfoundland and Labrador legislators in 2004 could have provided drugs for seven multiple sclerosis patients, a national organization says
   14-02-2007 to canada, drugs, government, multiple sclerosis by admin
5. BioMS Medical Cleared by FDA to Initiate Pivotal Phase III Multiple Sclerosis Trial
   "The clearance to proceed with a phase III trial in the US is asignificant step towards bringing MBP8298 to the worldwide market," saidKevin Giese, President and CEO of BioMS Medical.
   20-01-2007 to canada, clinical trial, drug company, drugs, mbp8298, multiple sclerosis, secondary progressive by admin
6. Health Canada approves promising new drug to treat multiple sclerosis
   Doctors in Canada can start prescribing Tysabri on Nov. 15 and patients will begin receiving monthly infusions in January.
   05-10-2006 to canada, drugs, government, multiple sclerosis, news, relapsing remitting, rrms, tysabri by admin
7. Genentech, Biogen say cancer drug helps against MS | Health | Reuters.co.uk
   Biotechnology companies Genentech Inc. and Biogen Idec Inc. on Monday said their cancer drug Rituxan showed hints of effectiveness against multiple sclerosis in a small mid-stage trial
   28-08-2006 to canada, chemotherapy, clinical trial, drug company, drugs, multiple sclerosis, research, rituxan, study, treatment, us by admin
8. BioMS Medical Announces Second Quarter 2006 Results
   More than 300 patients enrolled in pivotal phase II/III multiple sclerosis trial
   14-08-2006 to canada, clinical trial, drug company, drugs, multiple sclerosis, spms by admin
9. GW Pharmaceutical: Sativex
   GW pharmaceuticals is developing a portfolio of cannabis medicines the first of which, Sativex, received an Approval with Conditions from Health Canada in April 2005 for use as an adjunctive treatment for the symptom relief of neuropathic pain in MS
   17-07-2006 to canada, drug company, drugs, marijuana, multiple sclerosis, pain, sativex, uk by admin
10. Bioms Medical - Multiple Sclerosis
    BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies with emphasis on the treatment of multiple sclerosis (MS).
    17-06-2006 to canada, drug company, drugs, multiple sclerosis by admin

First / Previous / Next / Last / Page 1 of 1